# Promoting HIV Risk Reduction Among People Who Inject Drugs: A Stepped Care Approach Using Contingency Management With PrEP Adherence and Support Services

> **NCT04738825** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Yale University** · enrollment: 526 (estimated)

## Conditions studied

- Opioid-use Disorder
- HIV Prevention Program

## Interventions

- **BEHAVIORAL:** Contingency Management with stepped care to PrEP adherence and support services (CoMPASS)

## Key facts

- **NCT ID:** NCT04738825
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-10-04
- **Primary completion:** 2026-06-30
- **Final completion:** 2027-05-31
- **Target enrollment:** 526 (ESTIMATED)
- **Last updated:** 2026-05-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04738825

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04738825, "Promoting HIV Risk Reduction Among People Who Inject Drugs: A Stepped Care Approach Using Contingency Management With PrEP Adherence and Support Services". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04738825. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*